Track record · closed signal

Amazon.com, Inc. (AMZN) — closed signal from January 10, 2026

Partial Published before the outcome was known, scored automatically when the window closed on April 10, 2026.

Predicted vs. what happened

AMZN price · publication thesis → realized outcomesplit-adjusted
$247.38 Published $282.01 Target $238.38 Window close $248.94 Peak
$238.00 – $247.00Entry zone — fair-value band
$247.38Published — price the day we called it
$282.01Target — the price the thesis aimed for
$248.94Peak — highest point inside the window, not a realized return
$238.38Window close — end-of-window price, context only

What happened

Partial

Reached 4% of the predicted growth at its peak, without hitting the target.

Peak price
$248.94
peak on January 12, 2026 — not a realized return
Peak gain
+0.6%
peak, from the publication price
Window close
$238.38
end-of-window price, context only
Days to target
Window
January 10, 2026 – April 10, 2026

The thesis — published January 10, 2026

Predicted growth
+14%
over the measurement window
Target price
$282.01
the price the thesis aimed for
Entry zone
$238.00 – $247.00
the fair-value band we waited for
Price at publication
$247.38
published January 10, 2026
Confidence
66%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Amazon has a near-term boost from its expanding services, and steady income from its cloud and advertising businesses keeps the investment case grounded for the next few months. The pharmacy offering of a popular weight-loss pill on Jan 10 adds a new growth angle, but the stock moved up quickly so buying now is risky; prefer waiting for dips.

Primary drivers

  • Pharmacy offering of weight-loss pill supports services growth story
  • AWS and ad sales provide reliable, stabilizing revenue
  • Large company size makes it easier for investors to trade in and out
  • Buying on pullbacks lowers risk after fast price moves

How it played out

AMZN: the target was not reached

Lyra published AMZN at 247.38 on 2026-01-10 with a short-term thesis for 14% expected growth. The thesis pointed to Amazon's pharmacy offering of a weight-loss pill, steady cloud and advertising income, large-company liquidity, and waiting for pullbacks after a fast move.

Inside the window, AMZN peaked at 248.94 on 2026-01-12, a 0.6% gain. It stayed below the 282.01 target and never reached it. By 2026-04-10, it ended at 238.38. The thesis did not play out on price.

What happened during the window

On 2026-02-05, Amazon reported fourth-quarter results and discussed a large capital-spending plan for 2026. On 2026-04-09, The Wall Street Journal reported that Eli Lilly's weight-loss pill became available in the U.S., with access through Amazon Pharmacy among other platforms.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.